Industry Research Reports
Home > Reports > Service & Software > Global API Drug Development Service Market Outlook, In‑Depth Analysis & Forecast to 2031
Global API Drug Development Service Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Service & Software
Published Date: 2025-08-05
Pages: 149 Pages
Report ld: 4881835
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global API Drug Development Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Small Biotechs Companies accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
API Drug Development Service leading manufacturers including Lonza, Patheon, Catalent, Carbogen Amcis, Sterling Pharma Solutions, Cambrex, CordenPharma, Eurofins Scientific, Malvern Panalytical, Almac, etc., dominate supply; the top five capture approximately % of global revenue, with Lonza leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global API Drug Development Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Lonza
- Patheon
- Catalent
- Carbogen Amcis
- Sterling Pharma Solutions
- Cambrex
- CordenPharma
- Eurofins Scientific
- Malvern Panalytical
- Almac
- Pfizer
- Axplora
- Aptuit
- Porton
- Pharmaron Beijing
- Shanghai Haoyuan Chemexpress
- Stapharma
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Captive Product Development Service
- Commercial Product Development Service
Segment by Application
- Small Biotechs Companies
- Large Pharmaceutical Organizations
CHAPTER OUTLINE
Chapter 1: Defines the API Drug Development Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to API Drug Development Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global API Drug Development Service Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Captive Product Development Service
1.2.3 Commercial Product Development Service
1.3 Market Segmentation by Application
1.3.1 Global API Drug Development Service Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Small Biotechs Companies
1.3.3 Large Pharmaceutical Organizations
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global API Drug Development Service Revenue Estimates and Forecasts 2020-2031
2.2 Global API Drug Development Service Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global API Drug Development Service Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global API Drug Development Service Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Captive Product Development Service Market Size by Players
3.3.2 Commercial Product Development Service Market Size by Players
3.4 Global API Drug Development Service Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global API Drug Development Service Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global API Drug Development Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America API Drug Development Service Market Size by Type (2020-2031)
6.4 North America API Drug Development Service Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America API Drug Development Service Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe API Drug Development Service Market Size by Type (2020-2031)
7.4 Europe API Drug Development Service Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe API Drug Development Service Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific API Drug Development Service Market Size by Type (2020-2031)
8.4 Asia-Pacific API Drug Development Service Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific API Drug Development Service Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America API Drug Development Service Market Size by Type (2020-2031)
9.4 Central and South America API Drug Development Service Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America API Drug Development Service Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa API Drug Development Service Market Size by Type (2020-2031)
10.4 Middle East and Africa API Drug Development Service Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa API Drug Development Service Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Lonza
11.1.1 Lonza Corporation Information
11.1.2 Lonza Business Overview
11.1.3 Lonza API Drug Development Service Product Features and Attributes
11.1.4 Lonza API Drug Development Service Revenue and Gross Margin (2020-2025)
11.1.5 Lonza API Drug Development Service Revenue by Product in 2024
11.1.6 Lonza API Drug Development Service Revenue by Application in 2024
11.1.7 Lonza API Drug Development Service Revenue by Geographic Area in 2024
11.1.8 Lonza API Drug Development Service SWOT Analysis
11.1.9 Lonza Recent Developments
11.2 Patheon
11.2.1 Patheon Corporation Information
11.2.2 Patheon Business Overview
11.2.3 Patheon API Drug Development Service Product Features and Attributes
11.2.4 Patheon API Drug Development Service Revenue and Gross Margin (2020-2025)
11.2.5 Patheon API Drug Development Service Revenue by Product in 2024
11.2.6 Patheon API Drug Development Service Revenue by Application in 2024
11.2.7 Patheon API Drug Development Service Revenue by Geographic Area in 2024
11.2.8 Patheon API Drug Development Service SWOT Analysis
11.2.9 Patheon Recent Developments
11.3 Catalent
11.3.1 Catalent Corporation Information
11.3.2 Catalent Business Overview
11.3.3 Catalent API Drug Development Service Product Features and Attributes
11.3.4 Catalent API Drug Development Service Revenue and Gross Margin (2020-2025)
11.3.5 Catalent API Drug Development Service Revenue by Product in 2024
11.3.6 Catalent API Drug Development Service Revenue by Application in 2024
11.3.7 Catalent API Drug Development Service Revenue by Geographic Area in 2024
11.3.8 Catalent API Drug Development Service SWOT Analysis
11.3.9 Catalent Recent Developments
11.4 Carbogen Amcis
11.4.1 Carbogen Amcis Corporation Information
11.4.2 Carbogen Amcis Business Overview
11.4.3 Carbogen Amcis API Drug Development Service Product Features and Attributes
11.4.4 Carbogen Amcis API Drug Development Service Revenue and Gross Margin (2020-2025)
11.4.5 Carbogen Amcis API Drug Development Service Revenue by Product in 2024
11.4.6 Carbogen Amcis API Drug Development Service Revenue by Application in 2024
11.4.7 Carbogen Amcis API Drug Development Service Revenue by Geographic Area in 2024
11.4.8 Carbogen Amcis API Drug Development Service SWOT Analysis
11.4.9 Carbogen Amcis Recent Developments
11.5 Sterling Pharma Solutions
11.5.1 Sterling Pharma Solutions Corporation Information
11.5.2 Sterling Pharma Solutions Business Overview
11.5.3 Sterling Pharma Solutions API Drug Development Service Product Features and Attributes
11.5.4 Sterling Pharma Solutions API Drug Development Service Revenue and Gross Margin (2020-2025)
11.5.5 Sterling Pharma Solutions API Drug Development Service Revenue by Product in 2024
11.5.6 Sterling Pharma Solutions API Drug Development Service Revenue by Application in 2024
11.5.7 Sterling Pharma Solutions API Drug Development Service Revenue by Geographic Area in 2024
11.5.8 Sterling Pharma Solutions API Drug Development Service SWOT Analysis
11.5.9 Sterling Pharma Solutions Recent Developments
11.6 Cambrex
11.6.1 Cambrex Corporation Information
11.6.2 Cambrex Business Overview
11.6.3 Cambrex API Drug Development Service Product Features and Attributes
11.6.4 Cambrex API Drug Development Service Revenue and Gross Margin (2020-2025)
11.6.5 Cambrex Recent Developments
11.7 CordenPharma
11.7.1 CordenPharma Corporation Information
11.7.2 CordenPharma Business Overview
11.7.3 CordenPharma API Drug Development Service Product Features and Attributes
11.7.4 CordenPharma API Drug Development Service Revenue and Gross Margin (2020-2025)
11.7.5 CordenPharma Recent Developments
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Corporation Information
11.8.2 Eurofins Scientific Business Overview
11.8.3 Eurofins Scientific API Drug Development Service Product Features and Attributes
11.8.4 Eurofins Scientific API Drug Development Service Revenue and Gross Margin (2020-2025)
11.8.5 Eurofins Scientific Recent Developments
11.9 Malvern Panalytical
11.9.1 Malvern Panalytical Corporation Information
11.9.2 Malvern Panalytical Business Overview
11.9.3 Malvern Panalytical API Drug Development Service Product Features and Attributes
11.9.4 Malvern Panalytical API Drug Development Service Revenue and Gross Margin (2020-2025)
11.9.5 Malvern Panalytical Recent Developments
11.10 Almac
11.10.1 Almac Corporation Information
11.10.2 Almac Business Overview
11.10.3 Almac API Drug Development Service Product Features and Attributes
11.10.4 Almac API Drug Development Service Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Pfizer
11.11.1 Pfizer Corporation Information
11.11.2 Pfizer Business Overview
11.11.3 Pfizer API Drug Development Service Product Features and Attributes
11.11.4 Pfizer API Drug Development Service Revenue and Gross Margin (2020-2025)
11.11.5 Pfizer Recent Developments
11.12 Axplora
11.12.1 Axplora Corporation Information
11.12.2 Axplora Business Overview
11.12.3 Axplora API Drug Development Service Product Features and Attributes
11.12.4 Axplora API Drug Development Service Revenue and Gross Margin (2020-2025)
11.12.5 Axplora Recent Developments
11.13 Aptuit
11.13.1 Aptuit Corporation Information
11.13.2 Aptuit Business Overview
11.13.3 Aptuit API Drug Development Service Product Features and Attributes
11.13.4 Aptuit API Drug Development Service Revenue and Gross Margin (2020-2025)
11.13.5 Aptuit Recent Developments
11.14 Porton
11.14.1 Porton Corporation Information
11.14.2 Porton Business Overview
11.14.3 Porton API Drug Development Service Product Features and Attributes
11.14.4 Porton API Drug Development Service Revenue and Gross Margin (2020-2025)
11.14.5 Porton Recent Developments
11.15 Pharmaron Beijing
11.15.1 Pharmaron Beijing Corporation Information
11.15.2 Pharmaron Beijing Business Overview
11.15.3 Pharmaron Beijing API Drug Development Service Product Features and Attributes
11.15.4 Pharmaron Beijing API Drug Development Service Revenue and Gross Margin (2020-2025)
11.15.5 Pharmaron Beijing Recent Developments
11.16 Shanghai Haoyuan Chemexpress
11.16.1 Shanghai Haoyuan Chemexpress Corporation Information
11.16.2 Shanghai Haoyuan Chemexpress Business Overview
11.16.3 Shanghai Haoyuan Chemexpress API Drug Development Service Product Features and Attributes
11.16.4 Shanghai Haoyuan Chemexpress API Drug Development Service Revenue and Gross Margin (2020-2025)
11.16.5 Shanghai Haoyuan Chemexpress Recent Developments
11.17 Stapharma
11.17.1 Stapharma Corporation Information
11.17.2 Stapharma Business Overview
11.17.3 Stapharma API Drug Development Service Product Features and Attributes
11.17.4 Stapharma API Drug Development Service Revenue and Gross Margin (2020-2025)
11.17.5 Stapharma Recent Developments
12 API Drug Development ServiceIndustry Chain Analysis
12.1 API Drug Development Service Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 API Drug Development Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global API Drug Development Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global API Drug Development Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global API Drug Development Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global API Drug Development Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global API Drug Development Service Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global API Drug Development Service Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global API Drug Development Service Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global API Drug Development Service Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global API Drug Development Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in API Drug Development Service as of 2024)
Table 11. Global API Drug Development Service Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global API Drug Development Service Companies Headquarters
Table 13. Global API Drug Development Service Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global API Drug Development Service Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global API Drug Development Service Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global API Drug Development Service Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global API Drug Development Service Revenue by Application (2026-2031) & (US$ Million)
Table 21. API Drug Development Service High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America API Drug Development Service Growth Accelerators and Market Barriers
Table 25. North America API Drug Development Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe API Drug Development Service Growth Accelerators and Market Barriers
Table 27. Europe API Drug Development Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific API Drug Development Service Growth Accelerators and Market Barriers
Table 29. Asia-Pacific API Drug Development Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America API Drug Development Service Investment Opportunities and Key Challenges
Table 31. Central and South America API Drug Development Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa API Drug Development Service Investment Opportunities and Key Challenges
Table 33. Middle East and Africa API Drug Development Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Lonza Corporation Information
Table 35. Lonza Description and Major Businesses
Table 36. Lonza Product Features and Attributes
Table 37. Lonza Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Lonza Revenue Proportion by Product in 2024
Table 39. Lonza Revenue Proportion by Application in 2024
Table 40. Lonza Revenue Proportion by Geographic Area in 2024
Table 41. Lonza API Drug Development Service SWOT Analysis
Table 42. Lonza Recent Developments
Table 43. Patheon Corporation Information
Table 44. Patheon Description and Major Businesses
Table 45. Patheon Product Features and Attributes
Table 46. Patheon Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Patheon Revenue Proportion by Product in 2024
Table 48. Patheon Revenue Proportion by Application in 2024
Table 49. Patheon Revenue Proportion by Geographic Area in 2024
Table 50. Patheon API Drug Development Service SWOT Analysis
Table 51. Patheon Recent Developments
Table 52. Catalent Corporation Information
Table 53. Catalent Description and Major Businesses
Table 54. Catalent Product Features and Attributes
Table 55. Catalent Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Catalent Revenue Proportion by Product in 2024
Table 57. Catalent Revenue Proportion by Application in 2024
Table 58. Catalent Revenue Proportion by Geographic Area in 2024
Table 59. Catalent API Drug Development Service SWOT Analysis
Table 60. Catalent Recent Developments
Table 61. Carbogen Amcis Corporation Information
Table 62. Carbogen Amcis Description and Major Businesses
Table 63. Carbogen Amcis Product Features and Attributes
Table 64. Carbogen Amcis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Carbogen Amcis Revenue Proportion by Product in 2024
Table 66. Carbogen Amcis Revenue Proportion by Application in 2024
Table 67. Carbogen Amcis Revenue Proportion by Geographic Area in 2024
Table 68. Carbogen Amcis API Drug Development Service SWOT Analysis
Table 69. Carbogen Amcis Recent Developments
Table 70. Sterling Pharma Solutions Corporation Information
Table 71. Sterling Pharma Solutions Description and Major Businesses
Table 72. Sterling Pharma Solutions Product Features and Attributes
Table 73. Sterling Pharma Solutions Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Sterling Pharma Solutions Revenue Proportion by Product in 2024
Table 75. Sterling Pharma Solutions Revenue Proportion by Application in 2024
Table 76. Sterling Pharma Solutions Revenue Proportion by Geographic Area in 2024
Table 77. Sterling Pharma Solutions API Drug Development Service SWOT Analysis
Table 78. Sterling Pharma Solutions Recent Developments
Table 79. Cambrex Corporation Information
Table 80. Cambrex Description and Major Businesses
Table 81. Cambrex Product Features and Attributes
Table 82. Cambrex Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Cambrex Recent Developments
Table 84. CordenPharma Corporation Information
Table 85. CordenPharma Description and Major Businesses
Table 86. CordenPharma Product Features and Attributes
Table 87. CordenPharma Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. CordenPharma Recent Developments
Table 89. Eurofins Scientific Corporation Information
Table 90. Eurofins Scientific Description and Major Businesses
Table 91. Eurofins Scientific Product Features and Attributes
Table 92. Eurofins Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Eurofins Scientific Recent Developments
Table 94. Malvern Panalytical Corporation Information
Table 95. Malvern Panalytical Description and Major Businesses
Table 96. Malvern Panalytical Product Features and Attributes
Table 97. Malvern Panalytical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Malvern Panalytical Recent Developments
Table 99. Almac Corporation Information
Table 100. Almac Description and Major Businesses
Table 101. Almac Product Features and Attributes
Table 102. Almac Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Almac Recent Developments
Table 104. Pfizer Corporation Information
Table 105. Pfizer Description and Major Businesses
Table 106. Pfizer Product Features and Attributes
Table 107. Pfizer Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Pfizer Recent Developments
Table 109. Axplora Corporation Information
Table 110. Axplora Description and Major Businesses
Table 111. Axplora Product Features and Attributes
Table 112. Axplora Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Axplora Recent Developments
Table 114. Aptuit Corporation Information
Table 115. Aptuit Description and Major Businesses
Table 116. Aptuit Product Features and Attributes
Table 117. Aptuit Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Aptuit Recent Developments
Table 119. Porton Corporation Information
Table 120. Porton Description and Major Businesses
Table 121. Porton Product Features and Attributes
Table 122. Porton Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Porton Recent Developments
Table 124. Pharmaron Beijing Corporation Information
Table 125. Pharmaron Beijing Description and Major Businesses
Table 126. Pharmaron Beijing Product Features and Attributes
Table 127. Pharmaron Beijing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. Pharmaron Beijing Recent Developments
Table 129. Shanghai Haoyuan Chemexpress Corporation Information
Table 130. Shanghai Haoyuan Chemexpress Description and Major Businesses
Table 131. Shanghai Haoyuan Chemexpress Product Features and Attributes
Table 132. Shanghai Haoyuan Chemexpress Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. Shanghai Haoyuan Chemexpress Recent Developments
Table 134. Stapharma Corporation Information
Table 135. Stapharma Description and Major Businesses
Table 136. Stapharma Product Features and Attributes
Table 137. Stapharma Revenue (US$ Million) and Gross Margin (2020-2025)
Table 138. Stapharma Recent Developments
Table 139. Raw Materials Key Suppliers
Table 140. Distributors List
Table 141. Market Trends and Market Evolution
Table 142. Market Drivers and Opportunities
Table 143. Market Challenges, Risks, and Restraints
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. API Drug Development Service Product Picture
Figure 2. Global API Drug Development Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Captive Product Development Service Product Picture
Figure 4. Commercial Product Development Service Product Picture
Figure 5. Global API Drug Development Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Small Biotechs Companies
Figure 7. Large Pharmaceutical Organizations
Figure 8. API Drug Development Service Report Years Considered
Figure 9. Global API Drug Development Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 10. Global API Drug Development Service Revenue (2020-2031) & (US$ Million)
Figure 11. Global API Drug Development Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 12. Global API Drug Development Service Revenue Market Share by Region (2020-2031)
Figure 13. Global API Drug Development Service Revenue Market Share Ranking (2024)
Figure 14. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 15. Captive Product Development Service Revenue Market Share by Player in 2024
Figure 16. Commercial Product Development Service Revenue Market Share by Player in 2024
Figure 17. Global API Drug Development Service Revenue Market Share by Type (2020-2031)
Figure 18. Global API Drug Development Service Revenue Market Share by Application (2020-2031)
Figure 19. North America API Drug Development Service Revenue YoY (2020-2031) & (US$ Million)
Figure 20. North America Top 5 Players API Drug Development Service Revenue (US$ Million) in 2024
Figure 21. North America API Drug Development Service Revenue (US$ Million) by Type (2020 - 2031)
Figure 22. North America API Drug Development Service Revenue (US$ Million) by Application (2020-2031)
Figure 23. US API Drug Development Service Revenue (2020-2031) & (US$ Million)
Figure 24. Canada API Drug Development Service Revenue (2020-2031) & (US$ Million)
Figure 25. Mexico API Drug Development Service Revenue (2020-2031) & (US$ Million)
Figure 26. Europe API Drug Development Service Revenue YoY (2020-2031) & (US$ Million)
Figure 27. Europe Top 5 Players API Drug Development Service Revenue (US$ Million) in 2024
Figure 28. Europe API Drug Development Service Revenue (US$ Million) by Type (2020-2031)
Figure 29. Europe API Drug Development Service Revenue (US$ Million) by Application (2020-2031)
Figure 30. Germany API Drug Development Service Revenue (2020-2031) & (US$ Million)
Figure 31. France API Drug Development Service Revenue (2020-2031) & (US$ Million)
Figure 32. U.K. API Drug Development Service Revenue (2020-2031) & (US$ Million)
Figure 33. Italy API Drug Development Service Revenue (2020-2031) & (US$ Million)
Figure 34. Russia API Drug Development Service Revenue (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific API Drug Development Service Revenue YoY (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Top 8 Players API Drug Development Service Revenue (US$ Million) in 2024
Figure 37. Asia-Pacific API Drug Development Service Revenue (US$ Million) by Type (2020-2031)
Figure 38. Asia-Pacific API Drug Development Service Revenue (US$ Million) by Application (2020-2031)
Figure 39. Indonesia API Drug Development Service Revenue (2020-2031) & (US$ Million)
Figure 40. Japan API Drug Development Service Revenue (2020-2031) & (US$ Million)
Figure 41. South Korea API Drug Development Service Revenue (2020-2031) & (US$ Million)
Figure 42. Australia API Drug Development Service Revenue (2020-2031) & (US$ Million)
Figure 43. India API Drug Development Service Revenue (2020-2031) & (US$ Million)
Figure 44. Indonesia API Drug Development Service Revenue (2020-2031) & (US$ Million)
Figure 45. Vietnam API Drug Development Service Revenue (2020-2031) & (US$ Million)
Figure 46. Malaysia API Drug Development Service Revenue (2020-2031) & (US$ Million)
Figure 47. Philippines API Drug Development Service Revenue (2020-2031) & (US$ Million)
Figure 48. Singapore API Drug Development Service Revenue (2020-2031) & (US$ Million)
Figure 49. Central and South America API Drug Development Service Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Central and South America Top 5 Players API Drug Development Service Revenue (US$ Million) in 2024
Figure 51. Central and South America API Drug Development Service Revenue (US$ Million) by Type (2020-2031)
Figure 52. Central and South America API Drug Development Service Revenue (US$ Million) by Application (2020-2031)
Figure 53. Brazil API Drug Development Service Revenue (2020-2025) & (US$ Million)
Figure 54. Argentina API Drug Development Service Revenue (2020-2025) & (US$ Million)
Figure 55. Middle East and Africa API Drug Development Service Revenue YoY (2020-2031) & (US$ Million)
Figure 56. Middle East and Africa Top 5 Players API Drug Development Service Revenue (US$ Million) in 2024
Figure 57. South America API Drug Development Service Revenue (US$ Million) by Type (2020-2031)
Figure 58. Middle East and Africa API Drug Development Service Revenue (US$ Million) by Application (2020-2031)
Figure 59. GCC Countries API Drug Development Service Revenue (2020-2025) & (US$ Million)
Figure 60. Israel API Drug Development Service Revenue (2020-2025) & (US$ Million)
Figure 61. Egypt API Drug Development Service Revenue (2020-2025) & (US$ Million)
Figure 62. South Africa API Drug Development Service Revenue (2020-2025) & (US$ Million)
Figure 63. API Drug Development Service Industry Chain Mapping
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global API Drug Development Service market?
The top companies in the global API Drug Development Service market are Lonza、Patheon、Catalent.
Related Reports
Global API Drug Development Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global API Drug Development Service market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 160
USD 4900.00
(Single User License)
Global API Drug Development Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global API Drug Development Service market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 102
USD 4250.00
(Single User License)
API Drug Development Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for API Drug Development Service was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 131
USD 3950.00
(Single User License)
Global API Drug Development Service Market Research Report 2026
The global API Drug Development Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 136
USD 2900.00
(Single User License)
Global API Drug Development Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global API Drug Development Service market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 110
USD 4250.00
(Single User License)
API Drug Development Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for API Drug Development Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 131
USD 3950.00
(Single User License)
Global API Drug Development Service Market Research Report 2025
The global market for API Drug Development Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-11
Pages: 95
USD 2900.00
(Single User License)
Global API Drug Development Service Market Research Report 2024
The global API Drug Development Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Published Date: 2024-06-11
Pages: 95
USD 2900.00
(Single User License)
Global and United States API Drug Development Service Market Report & Forecast 2024-2030
The global API Drug Development Service revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published Date: 2024-06-11
Pages: 122
USD 4350.00
(Single User License)
Global API Drug Development Service Market Insights, Forecast to 2030
The global API Drug Development Service market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published Date: 2024-06-11
Pages: 153
USD 4900.00
(Single User License)
Global API Drug Development Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global API Drug Development Service market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 160
USD 4900.00 (Single User License)Global API Drug Development Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global API Drug Development Service market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 102
USD 4250.00 (Single User License)API Drug Development Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for API Drug Development Service was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 131
USD 3950.00 (Single User License)Global API Drug Development Service Market Research Report 2026
The global API Drug Development Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 136
USD 2900.00 (Single User License)Global API Drug Development Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global API Drug Development Service market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 110
USD 4250.00 (Single User License)API Drug Development Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for API Drug Development Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 131
USD 3950.00 (Single User License)Global API Drug Development Service Market Research Report 2025
The global market for API Drug Development Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-11
Pages: 95
USD 2900.00 (Single User License)Global API Drug Development Service Market Research Report 2024
The global API Drug Development Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Published: 2024-06-11
Pages: 95
USD 2900.00 (Single User License)Global and United States API Drug Development Service Market Report & Forecast 2024-2030
The global API Drug Development Service revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published: 2024-06-11
Pages: 122
USD 4350.00 (Single User License)Global API Drug Development Service Market Insights, Forecast to 2030
The global API Drug Development Service market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published: 2024-06-11
Pages: 153
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now